MUMBAI (Reuters) - The BSE Sensex and Nifty rose nearly 1 percent on Monday, marking their highest intraday level in two weeks as traders churned positions in favour of defensive stocks, especially among drug makers, a day ahead of the central bank's policy review.
Sun Pharmaceutical Industries surged as much as 9.2 percent during the day to mark a record high of 1,181 rupees, leading gains in the CNX Pharma Index.
The BSE Sensex and Nifty rose 0.86 percent each, after earlier marking their highest daily level since March 19.
(Reporting by Abhishek Vishnoi; Editing by Biju Dwarakanath)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app